Dual Contrast Molecular Imaging Allows Noninvasive Characterization of Myocardial Ischemia/Reperfusion Injury After Coronary Vessel Occlusion in Mice by MRI
暂无分享,去创建一个
M. Idzko | C. Bode | K. Peter | C. Muhlen | I. Neudorfer | A. Zirlik | D. Duerschmied | T. Heidt | P. Bronsert | M. Braig | M. Menza | Xiaowei Wang | D. Elverfeldt | A. Maier | M. Mauler | T. Witsch
[1] P. Kellman,et al. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Is Associated With Subsequent Hospitalization for Heart Failure , 2013, Journal of the American Heart Association.
[2] G. Hindricks,et al. Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? , 2013, European heart journal.
[3] R. Senior,et al. The hibernating myocardium: current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era. , 2013, European heart journal.
[4] W. Daniel,et al. A myocardial ischemia- and reperfusion-induced injury is mediated by reactive oxygen species released from blood platelets , 2013, Platelets.
[5] C. Bode,et al. In Vivo Detection of Activated Platelets Allows Characterizing Rupture of Atherosclerotic Plaques with Molecular Magnetic Resonance Imaging in Mice , 2012, PloS one.
[6] J. Schulz-Menger,et al. Functional and Morphological Cardiac Magnetic Resonance Imaging of Mice Using a Cryogenic Quadrature Radiofrequency Coil , 2012, PloS one.
[7] M. Olschewski,et al. Novel Single-Chain Antibody-Targeted Microbubbles for Molecular Ultrasound Imaging of Thrombosis: Validation of a Unique Noninvasive Method for Rapid and Sensitive Detection of Thrombi and Monitoring of Success or Failure of Thrombolysis in Mice , 2012, Circulation.
[8] M. Majmudar,et al. Cardiovascular Molecular Imaging: The Road Ahead , 2012, The Journal of Nuclear Medicine.
[9] Ahmed Tawakol,et al. PET/MRI of inflammation in myocardial infarction. , 2012, Journal of the American College of Cardiology.
[10] C. Higgins,et al. Delayed Contrast Enhancement on MR Images of Myocardium , 2011 .
[11] C. Bode,et al. Molecular Magnetic Resonance Imaging Allows the Detection of Activated Platelets in a New Mouse Model of Coronary Artery Thrombosis , 2011, Investigative radiology.
[12] U. Walter,et al. Phosphorylation of Vasodilator-Stimulated Phosphoprotein Prevents Platelet-Neutrophil Complex Formation and Dampens Myocardial Ischemia-Reperfusion Injury , 2011, Circulation.
[13] A. Dart,et al. Novel Role of Platelets in Mediating Inflammatory Responses and Ventricular Rupture or Remodeling Following Myocardial Infarction , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[14] Matthias Nahrendorf,et al. Molecular Imaging of Coronary Atherosclerosis and Myocardial Infarction: Considerations for the Bench and Perspectives for the Clinic , 2011, Circulation research.
[15] P. Conley,et al. Role of the P2Y12 Receptor in the Modulation of Murine Dendritic Cell Function by ADP , 2010, The Journal of Immunology.
[16] R. Jaffe,et al. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. , 2010, JACC. Cardiovascular interventions.
[17] Valerie A. Norton,et al. Fast volumetric spatial-spectral MR imaging of hyperpolarized 13C-labeled compounds using multiple echo 3D bSSFP. , 2010, Magnetic resonance imaging.
[18] M. Mirabet,et al. Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts , 2010, Thrombosis and Haemostasis.
[19] R. Virmani,et al. Microvascular obstruction: underlying pathophysiology and clinical diagnosis. , 2010, Journal of the American College of Cardiology.
[20] R. Choudhury,et al. An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide☆ , 2010, Atherosclerosis.
[21] S. Aime,et al. Current concepts on hyperpolarized molecules in MRI. , 2010, Current opinion in chemical biology.
[22] B. Gersh,et al. Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The “Dark Side” of Reperfusion , 2009, Circulation.
[23] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.
[24] K. Peter,et al. Single-chain antibodies as diagnostic tools and therapeutic agents , 2009, Thrombosis and Haemostasis.
[25] E. Antman,et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial , 2009, The Lancet.
[26] M. Olschewski,et al. Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis , 2008, Circulation.
[27] S. Neubauer,et al. Visualization of Activated Platelets by Targeted Magnetic Resonance Imaging Utilizing Conformation-Specific Antibodies against Glycoprotein IIb/IIIa , 2008, Journal of Vascular Research.
[28] C. Bode,et al. A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI. , 2008, The Journal of clinical investigation.
[29] C. Kramer,et al. Magnetic resonance for the assessment of myocardial viability , 2006, Current opinion in cardiology.
[30] C. Bode,et al. Conformation-Specific Blockade of the Integrin GPIIb/IIIa: A Novel Antiplatelet Strategy That Selectively Targets Activated Platelets , 2006, Circulation research.
[31] Roger B. Davis,et al. Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.
[32] M. Little,et al. Single-chain Antibodies for the Conformation-specific Blockade of Activated Platelet Integrin Α Iib Β 3 Designed by Subtractive Selection from Naïve Human Phage Libraries , 2022 .
[33] Gerhard Adam,et al. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. , 2004, Radiology.
[34] R. Kim,et al. Magnetic resonance imaging for the assessment of myocardial viability , 2004, Journal of magnetic resonance imaging : JMRI.
[35] C. Bode,et al. Reversibility versus Persistence of GPIIb/IIIa Blocker-Induced Conformational Change of GPIIb/IIIa (αIIbβ3, CD41/CD61) , 2004, Journal of Pharmacology and Experimental Therapeutics.
[36] J. Lima,et al. Myocardial viability assessment by contrast-enhanced magnetic resonance imaging. , 2003, Journal of the American College of Cardiology.
[37] P. Conley,et al. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. , 2003, The Journal of clinical investigation.
[38] E. Topol,et al. Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. , 2001, The American journal of cardiology.
[39] H. Ito. No reflow phenomenon in coronary heart disease. , 2001, Journal of cardiology.
[40] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[41] E. Antman,et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. , 1999, Circulation.
[42] P. Kistler,et al. Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients with Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death , 2010 .
[43] M. Gawaz,et al. [The role of platelets for the pathophysiology of acute coronary syndromes]. , 2006, Hamostaseologie.
[44] L. Becker. Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.